Home/Filings/4/0001257433-05-000005
4//SEC Filing

INTROGEN THERAPEUTICS INC 4

Accession 0001257433-05-000005

CIK 0001018710operating

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 8:01 PM ET

Size

5.7 KB

Accession

0001257433-05-000005

Insider Transaction Report

Form 4
Period: 2005-06-14
ALBRECHT JAMES W JR
Chief Executive Officer
Transactions
  • Award

    stock option

    2005-06-14+80,00080,000 total
    Exercise: $6.67Exp: 2015-06-09common stock (80,000 underlying)
Footnotes (2)
  • [F1]Right to buy.
  • [F2]This option vests in four equal annual installments beginning on the 12-month anniversary of June 10, 2005.

Issuer

INTROGEN THERAPEUTICS INC

CIK 0001018710

Entity typeoperating

Related Parties

1
  • filerCIK 0001018710

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 8:01 PM ET
Size
5.7 KB